Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dariusz Waniczek

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Biomedicines|November 11, 2022
Human Acellular Dermal Matrix in Reconstructive Surgery-A ReviewMarcin Gierek, Wojciech Łabuś, Diana Kitala, et al.
Contemporary Oncology (Poznan, Poland)|June 22, 2013
Analysis of PTEN expression in large intestine polyps and its relation to the recognized histopathological and clinical risk factors for cancer development in this locationDariusz Waniczek, Mirosław Snietura, Wojciech Pigłowski, et al.
Hepato-Gastroenterology|May 30, 2008
Neopterin--a potential factor for differentiation between pancreatic cancer and chronic pancreatitisJerzy Piecuch, Marek Rudzki, Witold Orkisz, et al.
Current Medical Science|June 25, 2021
GDF-15 Level Correlates with CMKLR1 and VEGF-A in Tumor-free Margin in Colorectal CancerSylwia Mielcarska, Kamila Stopińska, Miriam Dawidowicz, et al.
International Journal of Molecular Sciences|January 28, 2026
Association of TIGIT and CD155 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, MSI Status, and Cytokine Profiles in Colorectal CancerBłażej Ochman, Piotr Limanówka, Sylwia Mielcarska, et al.
International Journal of Molecular Sciences|July 29, 2025
TIM-3/Galectin-9 Immune Axis in Colorectal Cancer in Relation to KRAS, NRAS, BRAF, PIK3CA, AKT1 Mutations, MSI Status, and the Cytokine MilieuBłażej Ochman, Anna Kot, Sylwia Mielcarska, et al.
World Journal of Gastroenterology|August 12, 2014
Specific metabolic biomarkers as risk and prognostic factors in colorectal cancerMałgorzata Muc-Wierzgoń, Ewa Nowakowska-Zajdel, Sylwia Dzięgielewska-Gęsiak, et al.
Experimental and Molecular Pathology|January 14, 2020
Assessment of CMKLR1 level in colorectal cancer and its correlation with angiogenic markersPaweł Kiczmer, Alicja Prawdzic Seńkowska, Agnieszka Kula, et al.
Journal of Clinical Medicine|December 30, 2025
Taxonomic Profiling of Systemic Inflammatory Parameters as Predictors of Tumor Progression in Primary Colorectal CancerMichał Nycz, Dariusz Waniczek, Małgorzata Muc-Wierzgoń, et al.
Current Issues in Molecular Biology|December 27, 2024
Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal CancerBłażej Ochman, Anna Kot, Sylwia Mielcarska, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Biomedicines|November 11, 2022
Human Acellular Dermal Matrix in Reconstructive Surgery-A ReviewMarcin Gierek, Wojciech Łabuś, Diana Kitala, et al.
Contemporary Oncology (Poznan, Poland)|June 22, 2013
Analysis of PTEN expression in large intestine polyps and its relation to the recognized histopathological and clinical risk factors for cancer development in this locationDariusz Waniczek, Mirosław Snietura, Wojciech Pigłowski, et al.
Hepato-Gastroenterology|May 30, 2008
Neopterin--a potential factor for differentiation between pancreatic cancer and chronic pancreatitisJerzy Piecuch, Marek Rudzki, Witold Orkisz, et al.
Current Medical Science|June 25, 2021
GDF-15 Level Correlates with CMKLR1 and VEGF-A in Tumor-free Margin in Colorectal CancerSylwia Mielcarska, Kamila Stopińska, Miriam Dawidowicz, et al.
International Journal of Molecular Sciences|January 28, 2026
Association of TIGIT and CD155 with KRAS, NRAS, BRAF, PIK3CA, and AKT Gene Mutations, MSI Status, and Cytokine Profiles in Colorectal CancerBłażej Ochman, Piotr Limanówka, Sylwia Mielcarska, et al.
International Journal of Molecular Sciences|July 29, 2025
TIM-3/Galectin-9 Immune Axis in Colorectal Cancer in Relation to KRAS, NRAS, BRAF, PIK3CA, AKT1 Mutations, MSI Status, and the Cytokine MilieuBłażej Ochman, Anna Kot, Sylwia Mielcarska, et al.
World Journal of Gastroenterology|August 12, 2014
Specific metabolic biomarkers as risk and prognostic factors in colorectal cancerMałgorzata Muc-Wierzgoń, Ewa Nowakowska-Zajdel, Sylwia Dzięgielewska-Gęsiak, et al.
Experimental and Molecular Pathology|January 14, 2020
Assessment of CMKLR1 level in colorectal cancer and its correlation with angiogenic markersPaweł Kiczmer, Alicja Prawdzic Seńkowska, Agnieszka Kula, et al.
Journal of Clinical Medicine|December 30, 2025
Taxonomic Profiling of Systemic Inflammatory Parameters as Predictors of Tumor Progression in Primary Colorectal CancerMichał Nycz, Dariusz Waniczek, Małgorzata Muc-Wierzgoń, et al.
Current Issues in Molecular Biology|December 27, 2024
Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal CancerBłażej Ochman, Anna Kot, Sylwia Mielcarska, et al.
Pageof 7